[1]Fan Y, Borowsky AD, Weiss RH.An antisense oligodeoxynucleotideto p21 (Wafl/Cipl) causes apoptosis in human breast cancercells[J].Mol Cancer Ther, 2003, 2 (8) ∶773-782.
|
[2]Gorospe M, Cirielli C, Wang X, et al.P21 (Wafl/Cipl) protects a-gainst p53-mediated apoptosis of human melanoma cells[J].On-cogene, 1997, 14 (8) ∶929-935.
|
[3]Polyak K, Waldman T, He TC, et al.Genetic determinants of p53-induced apoptosis and growth arrest[J].Genes Dev, 1996, 10 (15) ∶1945-1952.
|
[4]Op De Beeck A, Caillet-Fauquet P.Viruses and the cell cycle[J].Prog Cell Cycle Res, 1997, 3 (2) ∶1-19.
|
[5]Davy C, Door bar J.G2/Mcell cycle arrest in the life cycle of viru-ses[J].Virology 2007, 368 (2) ∶219-226.
|
[6]Rodríguez-Vilarrupla A, Díaz C, Canela N, et al.Identification ofthe nuclear localization signal of p21 (cip1) and consequences of itsmutation on cell proliferation[J].FEBS Lett, 2002, 531 (2) ∶319-323.
|
[7]Deiry WS, Tokino T, Velculescu VE, et al.WAF1, a potential me-diator of p53 tumor suppression[J].Cell, 1993, 75 (4) ∶817-825.
|
[8]Child ES, Mann DJ.The intricacies of p21 phosphorylation:pro-tein/protein interactions, subcellular localization and stability[J].Cell Cycle, 2006, 5 (12) ∶1313-1319.
|
[9]Chen J, Saha P, Kornbluth S, et al.Cyclin-binding motifs are es-sential for the function of p21CIP1[J].Mol Cell Biol, 1996, 16 (9) ∶4673-4682.
|
[10]Shivji MK, Grey SJ, Strausfeld UP, et al.Cip1 inhibits DNArepli-cation but not PCNA-dependent nucleotide excision-repair[J].Curr Biol, 1994, 4 (12) ∶1062-1068.
|
[11]Nichols AF, Sancar A.Purification of PCNA as a nucleotide exci-sion repair protein[J].Nucleic Acids Res, 1992, 20 (10) ∶2441-2446.
|
[12]Cheng M, Olivier PJA.The p21cip1 and p27kip1 CDK“inhibi-tors”are essential activators of cyclin D-dependent kinases in mu-rine fibroblasts[J].Embo J, 1999, 18 (6) ∶1571-1583.
|
[13]La Baer, J, Garrett MD, Stevenson L F, et al.Newfunctional ac-tivities for the p21 family of CDK inhibitors[J].Genes Dev, 1997, 11 (7) ∶847-862.
|
[14]Suzuki A, Tsutomi Y, Akahane K, et al.Resistance to Fas-medi-ated apoptosis:Activation of caspase 3 is regulated by cell cycle reg-ulator p21WAF1 and IAP gene family ILP[J].Oncogene, 1998, 17 (8) ∶931-939.
|
[15]Suzuki A, Tsutomi Y, Miura M, et al.Caspase 3 inactivation tosuppress Fas-mediated apoptosis:Identification of binding domainwith p21 and ILP and inactivation machinery by p21[J].Onco-gene, 1999, 18 (5) ∶1239-1244.
|
[16]Asada M, Yamada T, Ichijo H, et al.Apoptosis inhibitory activityof cytoplasmic p21 (Cip1/WAF1) in monocytic differentiation[J].Embo J, 1999, 18 (5) ∶1223-1234.
|
[17]Harris CC, Hollstein M.Clinical implication of the p53 tumor-suppressor gene[J].NEngl J Med, 1993, 329 (18) ∶1318-1327.
|
[18]Park US, Park SK, Lee YI, et al.Hepatitis B virus-X protein up-regulates the expression of p21waf1/cip1 and prolongs G1/Stransi-tion via a p53-independent pathway in human hepatoma cells[J].Oncogene, 2000, 19 (30) ∶3384-3394.
|
[19]Ahn JY, Chung EY, Kwun HJ, et al.Transcriptional repression ofp21 (waf1) promoter by hepatitis B virus X protein via a p53-in-depen-dent pathway[J].Gene, 2001, 275 (1) ∶163-168.
|
[20]成军.肝炎病毒蛋白对肝细胞基因组转录调节及信号转导机制的影响[J].世界华人消化杂志, 2004, 12 (2) ∶253-257.
|
[21]Hae JH, Eun YJ, Woo JL, et al.Cooperative repression of cyclin-dependent kinase inhibitor p21 gene expression by hepatitis B virusX protein and hepatitis C virus core protein[J].FEBS Letters, 2002, 518 (1-3) ∶169-172.
|
[22]McKenzie PP, Danks MK, Kriwacki RW, et al.P21Waf1/Cipl dys-function in neuroblastoma:A novel mechanism of attenuating Go-G1 cell cycle arrest[J].Cancer Res, 2003, 63∶3840-3844.
|
[23]Wong SC, Chan JK, Lee KC, et al.Differential expression p16/p21/p27 and cydin D1/D3, and their relationships to cell prolifera-tion, apoptosis, and tumour progression in invasive ductal carcino-ma of the breast[J].J Pathol, 2001, 194 (1) ∶35-42.
|
[24]Krolewski B, Little JB.Overexpression of p21 protein in radiation-transformed mouse 10T 1/2 cell clones[J].Mol Carcinog, 2000, 27 (2) ∶141-148.
|
[1] | Yan WANG, Fujie ZHANG. Research advances in antiviral drugs for the treatment of hepatitis D[J]. Journal of Clinical Hepatology, 2023, 39(4): 776-784. doi: 10.3969/j.issn.1001-5256.2023.04.007 |
[2] | Siwen PENG, Guiwen GUAN, Ting ZHANG, Fengmin LU, Jia LIU, Xiangmei CHEN. Effect of cyclin D1 on HBV transcription and replication[J]. Journal of Clinical Hepatology, 2023, 39(2): 316-324. doi: 10.3969/j.issn.1001-5256.2023.02.010 |
[3] | Xueli YANG, Jianhua XUE, Tianyang CHEN, Jian PING, Tianlu HOU, Jianjie CHEN, Yang CHENG. Effect of atractylone on the viability and apoptosis of hepatoma HepG2 cells and related mechanism[J]. Journal of Clinical Hepatology, 2021, 37(11): 2589-2594. doi: 10.3969/j.issn.1001-5256.2021.11.020 |
[4] | Xiajie WEN, Guixin LI, Jie LI, Huiying RAO, Jidong JIA, Fengmin LU. Interaction between hepatitis B virus replication and lipid metabolism in patients with chronic hepatitis B and NAFLD[J]. Journal of Clinical Hepatology, 2021, 37(7): 1495-1500. doi: 10.3969/j.issn.1001-5256.2021.07.002 |
[5] | Xiong Fang, Gao Yao, Ma YanPin, Yu LeLe, Tan BingQin, Bao XuLi, Lu: Jun. Effect of interferon-α and thymopentin on the mRNA expression of APOBEC3A and APOBEC3B in HepG2.2.15 cells[J]. Journal of Clinical Hepatology, 2020, 36(1): 76-79. doi: 10.3969/j.issn.1001-5256.2020.01.017 |
[6] | Li Pei, Liu Yu. Effect of hepatitis B x gene on the expression of major histocompatibility complex class I chain-related gene A-A5. 1,invasion,and migration of HepG2. 2. 15 cells[J]. Journal of Clinical Hepatology, 2020, 36(4): 808-812. doi: 10.3969/j.issn.1001-5256.2020.04.020 |
[7] | Li YingYing, Zhan LiFen, Ceng ZheChao, Xu Shen. Effect of lobaplatin on proliferation and apoptosis of hepatocellular carcinoma HepG2 cells and related mechanism of action[J]. Journal of Clinical Hepatology, 2018, 34(4): 784-788. doi: 10.3969/j.issn.1001-5256.2018.04.018 |
[8] | Qiu Hua, Gao YueQiu, Mao DeWen, Zhou ZhenHua, Long FuLi, Wang MingGang. Construction of HBV whole-genome 1. 3 ploid HepG2 cell model and expression of HBV biomarkers[J]. Journal of Clinical Hepatology, 2017, 33(4): 668-673. doi: 10.3969/j.issn.1001-5256.2017.04.014 |
[9] | Jia XiaoLi, Shi JuanJuan, Feng Ting, Cheng YanAn, Wang Rui, Liu JingKun, Dang ShuangSuo. Effects of guggulsterone on proliferation and apoptosis of HepG2 human hepatocellular carcinoma cells[J]. Journal of Clinical Hepatology, 2013, 29(6): 452-455. |
[10] | Ke XiaoYu, Wang QiuJing, Yu Yuan, Liu ShenPei, Zhang ChunYan, Chen Yan, Yang Yan, Yang DongLiang. 17-AAG, an inhibitor of heat shock protein 90, down-regulates hepatitis B virus replication[J]. Journal of Clinical Hepatology, 2012, 28(6): 435-438. |
[11] | Gao Zhen, Zhang LunLi. Toll like receptors mediated innate immune responses against HBV infection[J]. Journal of Clinical Hepatology, 2011, 27(6): 667-669+673. |
[12] | Zou XiaoJing, Jiang XueQiang, Tian DeYing. Role of DC-SIGN on the maturation and activation of dendritic cells in chronic hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2011, 27(2): 145-147+153. |
[13] | Xiong QiXiang, Xiong LiJuan. Hepatitis B virus infection and DNA methylation in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2011, 27(8): 881-884. |
[14] | Jiang XiaoHua, Liu LingLing, Lei Chuang, Zhou QingPing. Effects of hepatitis C virus genotype 1b core protein on the gene expressions of Bax and Bcl-2 in HepG2 cells[J]. Journal of Clinical Hepatology, 2011, 27(5): 511-514. |
[15] | Yuan JianGuo, Wang XinGuo, Cui Xia, Liu FengHua, Wang FengHua, Song JiKui, Zhao HongKui. The activation of rat hepatic stellate cells stimulated with hepatitis B virus in vitro[J]. Journal of Clinical Hepatology, 2011, 27(2): 163-165. |
[16] | Xi HongLi, Liu FangFang, Yuan JiaYing, Yu YanYan. Significance and detection of IL-2、IL-4 and IFN-γ in PBMC from patients with hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2010, 26(6): 627-629. |
[17] | Shi YanMei, Lan YingHua, Dan Lei, Zhou Jin, Li YongGuo. The relationship between of hematopoietic stem cells and hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2010, 26(4): 377-380. |
[18] | Chen Sheng, Lin ChaoShuang. The relationship between liver function and immune system and viral replication in patients with viral hepatitis[J]. Journal of Clinical Hepatology, 2007, 23(2): 94-95. |
[19] | Yang XiaoJuan, Wu GuoRong, Lu ZhongHua, Pei Hao, Qian JinJuan. Clinical signification of detecting PreS;antigen for identifying viral replication in patients with HB without HbeAg[J]. Journal of Clinical Hepatology, 2007, 23(5): 340-341. |